Occult primary tumors of the head and neck: Lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose

Cancer

Volumn 86, Issue 1, 1999, Pages 114-118

  Greven, Kathryn M ^a   Keyes Jr , John W ^a   Williams III, Daniel W ^a   McGuirt, W Frederick ^a   Joyce III, William T ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Spartanburg Radiological Associates ^*  (United States)

Author keywords

Fluorodeoxyglucose; Head and neck cancer; Occult primary; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; HEAD CANCER; HUMAN; HUMAN TISSUE; MALE; NECK CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASMS, UNKNOWN PRIMARY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033168868     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990701)86:1<114::AID-CNCR16>3.0.CO;2-E     Document Type: Article

References (20)

1. Million RR, Cassisi NJ, Mancuso AA. The unknown primary. In: Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. 2nd edition. Philadelphia: Lippincott, 1994:311-20.
2. Fu KK. Neck node metastases from unknown primary. Front Radiat Ther Oncol 1994;28:66-78.
3. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology 1984;152:749-53.
4. Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau RJ, Herz M, Avril N, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous cell carcinomas. J Nucl Med 1995;36:1747-57.
5. Parsons JT. The effect of radiation on normal tissues of the head and neck. In: Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. 2nd edition. Philadelphia: Lippincott, 1994:245-89.
6. McGuirt WF, Greven KM, Keyes JW, Williams DW III, Watson NE, Geisinger KR, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 1995;104:274-8.
7. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186:27-35.
8. Zeitouni AG, Yamamoto L, Black M, Gjedde A. Functional imaging of head and neck tumors using positron emission tomography. J Otolaryngol 1994;23:77-80.
9. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102:281-8.
10. Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807-12.
11. Greven KM, Williams DW III, Keyes JW Jr., Watson N, McGuirt WF, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997;3: 353-7.
12. Lapela M, Grenman R, Kurki T, Heikki J, Leskinen S, Lindholm P, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-11.
13. Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-58.
14. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPECT. Radiology 1996;199:761-6.
15. Dillon WP, Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991;18:64-79.
16. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenberg JLN, Vaalburg W, Vermey A. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998;82:1160-6.
17. Wong WL, Hussain K, Chevretton E, Hawkes DJ, Baddeley H, Maisey M, et al. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 1996;172:628-32.
18. Chisin R, Pietrzyk U, Sichel J-Y, Rubinstein R, Yaffe S, Bocher M, et al. Registration and display of multimodal images: applications in the extracranial head and neck region. J Otolaryngol 1993;22:214-9.
19. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-15.
20. Lindholm P, Leskinen-Kallio S, Minn H, Bergman J, Haaparanta M, Lehikoinen P, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J Nucl Med 1993;34:1711-6.